ArticlePlastic and reconstructive surgery. Global open2026
Management of Supraclavicular Nerve Transection With Regenerative Peripheral Nerve Interface During Neurogenic Thoracic Outlet Decompression.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic pain is a known complication following neurogenic thoracic outlet syndrome (nTOS) procedures, often resulting from supraclavicular nerve (SCN) injury and neuroma formation. Despite its clinical significance, there is limited literature on techniques to address the SCN in nTOS surgery. This study evaluates the use of regenerative peripheral nerve interface (RPNI) to mitigate neuropathic pain and reduce the risk of symptomatic neuroma formation when the SCN is divided during nTOS surgery. Methods: A retrospective review was conducted of 12 patients who underwent supraclavicular nTOS surgery with RPNI of the SCN between 2021 and 2024. The SCN and its branches were coapted to an autologous free muscle graft, secured within its epimysium, and folded to complete the RPNI. The omohyoid was used as the donor muscle in most cases. Results: A total of 12 patients (median age 32 y) underwent SCN RPNI at the time of nTOS decompression. The omohyoid was used in 7 cases, the scalene in 3, the trapezius in 1, and the sternocleidomastoid in 1. At follow-up (mean 11 mo), most patients reported improvement in nTOS-related symptoms. Five patients, all with prior nTOS surgery, reported persistent discomfort reflecting ongoing nTOS rather than new focal supraclavicular neuropathic pain. No clinical symptoms characteristic of supraclavicular neuromas were observed at short-term follow-up. Conclusions: RPNI of the SCN is a feasible adjunct during supraclavicular nTOS when the nerve must be divided, with no clinically evident neuromas observed at short-term follow-up. Larger controlled studies with standardized outcome measures are needed to clarify its independent impact.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.